- Home
- OBIO vs TCX Comparison
OBIO vs TCX Comparison
Compare OBIO & TCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- TCX
- Stock Information
- Founded
- OBIO 2017
- TCX 1992
- Country
- OBIO United States
- TCX Canada
- Employees
- OBIO N/A
- TCX N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- TCX EDP Services
- Sector
- OBIO Health Care
- TCX Technology
- Exchange
- OBIO Nasdaq
- TCX Nasdaq
- Market Cap
- OBIO 200.1M
- TCX 179.0M
- IPO Year
- OBIO N/A
- TCX 1996
- Fundamental
- Price
- OBIO $5.84
- TCX $15.99
- Analyst Decision
- OBIO Strong Buy
- TCX
- Analyst Count
- OBIO 4
- TCX 0
- Target Price
- OBIO $15.75
- TCX N/A
- AVG Volume (30 Days)
- OBIO 57.1K
- TCX 44.4K
- Earning Date
- OBIO 11-12-2024
- TCX 11-07-2024
- Dividend Yield
- OBIO N/A
- TCX N/A
- EPS Growth
- OBIO N/A
- TCX N/A
- EPS
- OBIO N/A
- TCX N/A
- Revenue
- OBIO $2,647,000.00
- TCX $356,135,000.00
- Revenue This Year
- OBIO $7.68
- TCX $8.16
- Revenue Next Year
- OBIO $110.40
- TCX N/A
- P/E Ratio
- OBIO N/A
- TCX N/A
- Revenue Growth
- OBIO N/A
- TCX 7.50
- 52 Week Low
- OBIO $4.22
- TCX $15.01
- 52 Week High
- OBIO $11.69
- TCX $28.66
- Technical
- Relative Strength Index (RSI)
- OBIO 51.19
- TCX 31.56
- Support Level
- OBIO $5.56
- TCX $15.01
- Resistance Level
- OBIO $6.50
- TCX $17.32
- Average True Range (ATR)
- OBIO 0.53
- TCX 0.98
- MACD
- OBIO 0.00
- TCX -0.19
- Stochastic Oscillator
- OBIO 56.58
- TCX 19.14
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About TCX Tucows Inc.
Tucows Inc is a corporate parent, allocating capital and providing efficient shared services to its three businesses. The Company offers Mobile Service Enabler (MSE) solutions, as well as professional services to other retail mobile providers. The Company is also a distributor of Internet services, including domain name registration, digital certificates, and email. It provides these services through an Internet-based distribution network of Internet Service Providers, web hosting companies, and other providers of Internet services to end-users. It operates in three segments: Ting, Wavelo, and Tucows Domains. It generates the majority of its revenue from Tucows Domains.